Portfolio company
Scope Biosciences
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops CRISPR-based molecular diagnostic kits for on-site pathogen detection for agricultural growers and healthcare providers.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Sherlock Biosciences
This company develops molecular diagnostic tests using CRISPR and synthetic biology for healthcare providers and consumers to detect infectious diseases and other health conditions.
VedaBio
This company develops CRISPR-based molecular diagnostic instruments and cartridges for healthcare providers, urgent care clinics and diagnostic laboratories to enable rapid testing.
DiagonalBio
This company develops molecular diagnostic systems for rapid, point-of-care pathogen detection in human healthcare, veterinary, and agricultural markets.
D-Nome
This company develops point-of-care molecular diagnostic kits and genomic sequencing tools for healthcare providers, laboratories, and agricultural clients to detect infectious diseases.
SeQureDX
This company provides off-target gene-editing analysis and safety diagnostics for biotechnology and pharmaceutical firms developing CRISPR-based therapies.
SwissDecode
This company provides rapid on-site DNA testing kits for the food and agriculture industries to detect specific crop diseases and product qualities.
Mammoth
This company develops CRISPR-based molecular diagnostics and gene-editing therapies for pharmaceutical partners and healthcare providers.
Alveo
This company develops portable molecular diagnostic platforms for rapid pathogen detection in agriculture, food safety, environmental monitoring, and human healthcare sectors.